Literature DB >> 26150545

Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.

Patrick Driguez1, Yuesheng Li2, Soraya Gaze3, Mark S Pearson4, Rie Nakajima5, Angela Trieu1, Denise L Doolan1, Philip L Felgner5, Xunya Hou6, Fernanda C Cardoso7, Algis Jasinskas5, Geoffrey N Gobert1, Alex Loukas4, Donald P McManus1.   

Abstract

Infection with Schistosoma japonicum causes high levels of pathology that is predominantly determined by the cellular and humoral response of the host. However, the specific antibody response that arises during the development of disease is largely undescribed in Asian schistosomiasis-endemic populations. A schistosome protein microarray was used to compare the antibody profiles of subjects with acute infection, with early or advanced disease associated with severe pathology, with chronic infection, and subjects exposed but stool negative for S. japonicum eggs to the antibody profiles of nonexposed controls. Twenty-five immunodominant antigens were identified, including vaccine candidates, tetraspanin-related proteins, transporter molecules, and unannotated proteins. Additionally, individuals with severe pathology had a limited specific antibody response, suggesting that individuals with mild disease may use a broad and strong antibody response, particularly against surface-exposed proteins, to control pathology and/or infection. Our study has identified specific antigens that can discriminate between S. japonicum-exposed groups with different pathologies and may also allow the host to control disease pathology and provide resistance to parasite infection.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Schistosoma japonicum; antibody; human disease; immunology; protein microarray; schistosomiasis

Mesh:

Substances:

Year:  2015        PMID: 26150545     DOI: 10.1093/infdis/jiv356

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Antibody Profiling by Proteome Microarray with Multiplex Isotype Detection Reveals Overlap between Human and Aotus nancymaae Controlled Malaria Infections.

Authors:  Omid Taghavian; Aarti Jain; Chester J Joyner; Sunny Ketchum; Rie Nakajima; Algis Jasinskas; Li Liang; Rich Fong; Christopher King; Bryan Greenhouse; Maxwell Murphy; Jason Bailey; Mary R Galinski; John W Barnwell; Christopher V Plowe; D Huw Davies; Philip L Felgner
Journal:  Proteomics       Date:  2018-01       Impact factor: 3.984

Review 2.  Schistosomiasis vaccines: where do we stand?

Authors:  Biniam Mathewos Tebeje; Marina Harvie; Hong You; Alex Loukas; Donald P McManus
Journal:  Parasit Vectors       Date:  2016-09-30       Impact factor: 3.876

3.  Distinct antibody responses of patients with mild and severe leptospirosis determined by whole proteome microarray analysis.

Authors:  Carolina Lessa-Aquino; Janet C Lindow; Arlo Randall; Elsio Wunder; Jozelyn Pablo; Rie Nakajima; Algis Jasinskas; Jaqueline S Cruz; Alcineia O Damião; Nívison Nery; Guilherme S Ribeiro; Federico Costa; José E Hagan; Mitermayer Galvão Reis; Albert I Ko; Marco Alberto Medeiros; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2017-01-31

4.  Quantitative multiplexed proteomics of Taenia solium cysts obtained from the skeletal muscle and central nervous system of pigs.

Authors:  José Navarrete-Perea; Marta Isasa; Joao A Paulo; Ricardo Corral-Corral; Jeanette Flores-Bautista; Beatriz Hernández-Téllez; Raúl J Bobes; Gladis Fragoso; Edda Sciutto; Xavier Soberón; Steven P Gygi; Juan P Laclette
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

5.  Identification of Cytauxzoon felis antigens via protein microarray and assessment of expression library immunization against cytauxzoonosis.

Authors:  Megan E Schreeg; Henry S Marr; Jaime L Tarigo; Meredith K Sherrill; Hilton K Outi; Elizabeth H Scholl; David M Bird; Adam Vigil; Chris Hung; Rie Nakajima; Li Liang; Angela Trieu; Denise L Doolan; Jennifer E Thomas; Michael G Levy; Mason V Reichard; Philip L Felgner; Leah A Cohn; Adam J Birkenheuer
Journal:  Clin Proteomics       Date:  2018-12-29       Impact factor: 3.988

6.  Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.

Authors:  Paul McCusker; Claudia M Rohr; John D Chan
Journal:  PLoS Negl Trop Dis       Date:  2021-03-03

7.  Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study.

Authors:  Mark S Pearson; Bemnet A Tedla; Gebeyaw G Mekonnen; Carla Proietti; Luke Becker; Rie Nakajima; Al Jasinskas; Denise L Doolan; Abena S Amoah; Stefanie Knopp; David Rollinson; Said M Ali; Fatma Kabole; Cornelis H Hokke; Akim A Adegnika; Matt A Field; Govert van Dam; Paul L A M Corstjens; Takafira Mduluza; Francisca Mutapi; Claude Oeuvray; Beatrice Greco; Sujittra Chaiyadet; Thewarach Laha; Pengfei Cai; Donald P McManus; Maria Elena Bottazzi; Philip L Felgner; Javier Sotillo; Alex Loukas
Journal:  Lancet Microbe       Date:  2021-11

8.  Identification of a linear B-cell epitope on the Schistosoma japonicum saposin protein, SjSAP4: Potential as a component of a multi-epitope diagnostic assay.

Authors:  Yi Mu; Catherine A Gordon; Remigio M Olveda; Allen G Ross; David U Olveda; Jessica M Marsh; Donald P McManus; Pengfei Cai
Journal:  PLoS Negl Trop Dis       Date:  2022-07-11

9.  Effects of Polymorphisms in the SjSP-13 Gene of Schistosoma japonicum on Its Diagnostic Efficacy and Immunogenicity.

Authors:  Xindong Xu; Xiaobing Cui; Liufang Zhu; Zhengli Li; Yuanbin Zhang; Li Ma; Weiqing Pan
Journal:  Front Microbiol       Date:  2018-07-25       Impact factor: 5.640

10.  Identification of linear epitopes in SjSP-13 of Schistosoma japonicum using a GST-peptide fusion protein microplate array.

Authors:  Li Ma; Wenrong Zhao; Xunya Hou; Mengmeng Liu; Yanna Li; Li Shen; Xindong Xu
Journal:  Parasit Vectors       Date:  2019-10-30       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.